YUPELRI

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Nov 09, 2018

   7 yr 9 mo ago

2. Today

3. Patent 7288657 expires

   Listed drug substance patent expiration.

   Oct 31, 2028

   in 2 yr 5 mo

4. Patent 10550081 expires

   Listed drug substance patent expiration.

   Jul 14, 2030

   in 4 yr 2 mo

5. Patent 11008289 expires

   Listed method-of-use patent (U-2440) expiration.

   Jul 14, 2030

   in 4 yr 2 mo

6. Patent 11691948 expires

   Listed drug product patent expiration.

   Jul 14, 2030

   in 4 yr 2 mo

7. Patent 11858898 expires

   Listed drug substance patent expiration.

   Jul 14, 2030

   in 4 yr 2 mo

8. Patent 9765028 expires

   Listed drug substance patent expiration.

   Jul 14, 2030

   in 4 yr 2 mo

9. Patent 8541451 expires

   Listed drug substance patent expiration.

   Aug 25, 2031

   in 5 yr 3 mo

10. Patent 12048692 expires

    Listed method-of-use patent (U-2440) expiration.

    Aug 29, 2039

    in 13 yr 5 mo

11. Patent 12285417 expires

    Listed method-of-use patent (U-2440) expiration.

    Aug 29, 2039

    in 13 yr 5 mo

12. Patent 11484531 expires

    Listed method-of-use patent (U-2440) expiration.

    Oct 23, 2039

    in 13 yr 6 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (10)